| Company Name: |
Shanghai Hongye Biotechnology Co. Ltd
|
| Tel: |
400-9205774 400-920-5774 |
| Email: |
sales@glpbio.cn |
| Products Intro: |
Product Name:RK-20448
CAS:479501-40-1
Purity:>98% Package:1mg;10mg;50mg;100mg;
|
| Company Name: |
BOC Sciences
|
| Tel: |
16314854226 |
| Email: |
info@bocsci.com |
| Products Intro: |
Product Name:RK-20448
CAS:479501-40-1
Purity:≥98% Remarks:RK-20448 is the cis-isomer of A-419259. RK-20448 acts as an ATP-competitive inhibitor of Lck, Src, KDR/VEGF2R, and Tie-2 (IC50s = 0.24, 1.19, 10.74, and 5.85 μM, respectively).
|
| Company Name: |
ChemeGen(Shanghai) Biotechnology Co.,Ltd.
|
| Tel: |
18818260767 |
| Email: |
sales@chemegen.com |
| Products Intro: |
Product Name:RK-20448
CAS:479501-40-1
Purity:98% Package:10 mg;50 mg;100 mg;500 mg;1 g;5 g;10 g
|
| Company Name: |
Energy Chemical
|
| Tel: |
021-58432009 400-005-6266 |
| Email: |
marketing1@energy-chemical.com |
| Products Intro: |
Product Name:RK20448-Trihydrochloride
CAS:479501-40-1
Purity:NULL Package:100mg;10mg;25mg;50mg Remarks:NULL
|
|
| | RK-20448 Basic information |
| Product Name: | RK-20448 | | Synonyms: | RK-20448;7H-Pyrrolo[2,3-d]pyrimidin-4-amine, 7-[cis-4-(4-methyl-1-piperazinyl)cyclohexyl]-5-(4-phenoxyphenyl)-;RK20449 HCK inhibitor (Cis);RK20449 HCK inhibitor (Trans);7-((1s,4s)-4-(4-methylpiperazin-1-yl)cyclohexyl)-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (relative stereochemistry shown) | | CAS: | 479501-40-1 | | MF: | C29H34N6O | | MW: | 482.62 | | EINECS: | | | Product Categories: | | | Mol File: | 479501-40-1.mol |  |
| | RK-20448 Chemical Properties |
| Boiling point | 686.427±55.00 °C(Press: 760.00 Torr)(predicted) | | density | 1.297±0.14 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted) | | storage temp. | Store at -20°C | | solubility | DMSO: 10 mM | | form | A solid | | pka | 8.202±0.42(predicted) | | color | White to off-white |
| | RK-20448 Usage And Synthesis |
| Uses | RK 20448-Trihydrochloride is a relative of A 419259 Trihydrochloride (A101040), which is the hydrochloride form of A 419259, a Src kinase inhibitor and can be used in treatment of chronic myelogenous leukemia, lymphangioleiomyomatosis and tuberous sclerosis. | | IC 50 | Lck: 0.24 μM (IC50); Blk: 0.37 μM (IC50); Fyn: 2.03 μM (IC50); Tie2: 5.85 μM (IC50); VEGFR2: 10.74 μM (IC50) |
| | RK-20448 Preparation Products And Raw materials |
|